The effect of cumin pearl on treatment of obesity
Phase 3
- Conditions
- Obesity and overweight.Obesity
- Registration Number
- IRCT2014043012438N8
- Lead Sponsor
- Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 87
Inclusion Criteria
Overweight (Body mass index range: 25.2–48.8 kg/m 2)
Aged 18–60
Exclusion Criteria
Those with malignancy
Metabolic disorders
Thyroid disorders
Cardiovascular disorders
Pregnancy and lactation
Those using hormonal, antidiabetic, or anti-obesity medications
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Weight change. Timepoint: Baseline and end of study. Method of measurement: Scale.
- Secondary Outcome Measures
Name Time Method Total cholesterol. Timepoint: Baseline and end of study. Method of measurement: Enzymatic kit.;Insulin. Timepoint: Baseline and end of study. Method of measurement: ELISA kit.;Triglycerides. Timepoint: Baseline and end of study. Method of measurement: Enzymatic kit.;HDL-cholesterol. Timepoint: Baseline and end of study. Method of measurement: Enzymatic kit.;LDL-cholesterol. Timepoint: Baseline and end of study. Method of measurement: Enzymatic kit.;Glutathione. Timepoint: Baseline and end of study. Method of measurement: Spectrophotometry.;Fasting plasma glucose. Timepoint: Baseline and end of study. Method of measurement: Enzymatic kit.;Insulin resistance. Timepoint: Baseline and end of study. Method of measurement: Calculation using HOMA formula.;Thyroid hormones. Timepoint: Baseline and end of study. Method of measurement: ELISA kit.;Total antioxidant capacity. Timepoint: Baseline and end of study. Method of measurement: Spectrophotometry.